Descriptive statistics for both Indiana Biobank cohorts are presented in Table 1. 31.30% of liver diseases cohort and 28.04% of SUD cohort participants were determined to have ICD codes denoting remission. In the liver diseases cohort, participants in the remitted group had higher PGSAUD and a lower proportion of females than participants with current AUD. In the SUD cohort, the same trends were observed for PGSAUD and percentage of females, but these differences did not reach significance. In both cohorts, remitted participants were younger than individuals with current AUD. Table 2 displays regression results. PGSAUD were positively associated with remission in the liver diseases cohort but had no association in the SUD cohort. Female sex and older age significantly decreased the probability of remission in both Indiana cohorts.
